PUBLISHER: Market Research Future | PRODUCT CODE: 1327676
PUBLISHER: Market Research Future | PRODUCT CODE: 1327676
The growth of the Europe life science & analytical instruments market is attributed to the rising demand for analytical instruments in different sectors, increasing strategic initiatives in the life science and analytical instruments market, the growing prevalence of Hospital-acquired Infections (HAIs), and untapped emerging economies. However, the dearth of skilled professionals is anticipated to hamper the market growth.
Life science is the scientific study of living organisms, including their physical and chemical structure, function, development, evolution, and ecology. Life science analytical instruments are used in hospitals, diagnostic laboratories, and pharmaceutical companies. Additionally, these instruments can be utilized for a variety of purposes, including evaluating the components, content, and quality of materials used in drug development.
Life science is the scientific study of living organisms, including their physical and chemical structure, function, development, evolution, and ecology. Life science analytical instruments are used in hospitals, diagnostic laboratories, and pharmaceutical companies. Additionally, these instruments can be utilized for a variety of purposes, including evaluating the components, content, and quality of materials used in drug development.
Based on the type, the Europe life science & analytical instruments market has been divided into microscopy, chromatography, cell counting, spectroscopy, PCR, electrophoresis, flow cytometry, next-generation sequencing, centrifuge instruments, cryogenic instruments, and others.
Based on application, the Europe life science & analytical instruments market has been categorized into clinical and diagnostics applications, research applications and others.
Based on end user, the Europe life science & analytical instruments market has been categorized into pharmaceutical and biotechnology companies, hospitals and diagnostic laboratories, and others.
Factors such as a boost in the biopharmaceutical sector in the European region, rising government initiatives to promote research to find a cure to the increasing number of chronic diseases, a growing number of pharmaceutical manufacturers, improving economies, high disposable income per individual, and increased healthcare spending are driving the growth of the market in this region. Furthermore, the growing R&D activities and the developing biopharmaceutical sector are also expected to drive the European market. The availability of high-end technologies in countries like Germany and growing funding from various public as well as private sources to conduct advanced research are fostering market growth. Europe-based companies are also boosting the market with active collaborations and mergers & acquisitions.
Thermo Fisher Scientific Inc., Merck KGAA, BD., Agilent Technologies, Inc., and PerkinElmer Inc.
TABLE OF CONTENTS